ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Adding TTFields to Chemotherapy to Improves Survival in Glioblastoma

Roger Stupp, MD
Published Online:6:23 PM, Thu January 18, 2018

Roger Stupp, MD, professor, Neurological Surgery, and associate director, Strategic Initiatives, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, discusses final results of a randomized, multi-center, phase III trial investigating tumor treating fields (TTFields) added to standard chemotherapy in newly diagnosed glioblastoma during the AACR Annual Meeting.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.